Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining the "Frequent Exacerbator" Phenotype in COPD: A Hypothesis-Free Approach.
Le Rouzic O, Roche N, Cortot AB, Tillie-Leblond I, Masure F, Perez T, Boucot I, Hamouti L, Ostinelli J, Pribil C, Poutchnine C, Schück S, Pouriel M, Housset B. Le Rouzic O, et al. Among authors: housset b. Chest. 2018 May;153(5):1106-1115. doi: 10.1016/j.chest.2017.10.009. Epub 2017 Oct 17. Chest. 2018. PMID: 29054347
Response.
Le Rouzic O, Roche N, Housset B. Le Rouzic O, et al. Among authors: housset b. Chest. 2019 Jan;155(1):241-242. doi: 10.1016/j.chest.2018.09.001. Chest. 2019. PMID: 30616729 No abstract available.
Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021.
Zysman M, Baptista BR, Soumagne T, da Silva VM, Martin C, de Menonville CT, Boyer L, Degano B, Burgel PR, Perez T, Bourdin A, Raherison C, Pégliasco H, Piperno D, Zanetti C, Morel H, Delclaux B, Delafosse C, Lorenzo A, Housset B, Morélot-Panzini C, Chabot F, Devillier P, Deslée G, Roche N. Zysman M, et al. Among authors: housset b. Respir Med Res. 2022 May;81:100889. doi: 10.1016/j.resmer.2022.100889. Epub 2022 Feb 23. Respir Med Res. 2022. PMID: 35219225 Free article. No abstract available.
[Chronic obstructive pulmonary disease].
Roche N, Housset B, Postel-Vinay N. Roche N, et al. Among authors: housset b. Rev Mal Respir. 2006 Feb;23(1 Pt 2):2S39-48. Rev Mal Respir. 2006. PMID: 16802413 Review. French. No abstract available.
Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic.
Morélot-Panzini C, Adler D, Aguilaniu B, Allard E, Bautin N, Beaumont M, Blanc FX, Chenivesse C, Dangers L, Delclaux C, Demoule A, Devillier P, Didier A, Georges M, Housset B, Janssens JP, Laveneziana P, Laviolette L, Muir JF, Ninot G, Perez T, Peiffer C, Schmidt M, Similowski T, Straus C, Taillé C, Van Den Broecke S, Roche N; dyspnoea working group of the Société de Pneumologie de Langue Française. Morélot-Panzini C, et al. Among authors: housset b. Eur Respir J. 2017 Sep 27;50(3):1701159. doi: 10.1183/13993003.01159-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28954773 Free article. No abstract available.
Pharmacological treatment optimisation for stable COPD: an endless story? Proposals from the Société de Pneumologie de Langue Française.
Zysman M, Chabot F, Housset B, Morelot Panzini C, Devillier P, Roche N; Société de Pneumologie de Langue Française. Zysman M, et al. Among authors: housset b. Eur Respir J. 2017 Oct 12;50(4):1701250. doi: 10.1183/13993003.01250-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29025880 Free article. No abstract available.
[Economic burden of COPD: the SCOPE study].
Fournier M, Tonnel AB, Housset B, Huchon G, Godard P, Vervloet D, Huas D, Durand-Zaleski I, Chanal I, Pribil C; Groupe SCOPE. Fournier M, et al. Among authors: housset b. Rev Mal Respir. 2005 Apr;22(2 Pt 1):247-55. doi: 10.1016/s0761-8425(05)85478-6. Rev Mal Respir. 2005. PMID: 16092163 French.
208 results